Pulse Biosciences, Inc. (PLSE)
50.84
+3.29
(+6.92%)
USD |
NASDAQ |
Oct 20, 16:00
50.72
-0.12
(-0.24%)
Pre-Market: 20:00
Pulse Biosciences Research and Development Expense (TTM) : 51.89M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 51.89M |
| March 31, 2026 | 47.00M |
| December 31, 2025 | 44.72M |
| September 30, 2025 | 44.46M |
| June 30, 2025 | 40.77M |
| March 31, 2025 | 35.91M |
| December 31, 2024 | 32.34M |
| September 30, 2024 | 29.47M |
| June 30, 2024 | 29.24M |
| March 31, 2024 | 28.71M |
| December 31, 2023 | 27.74M |
| September 30, 2023 | 23.96M |
| June 30, 2023 | 21.00M |
| March 31, 2023 | 19.76M |
| December 31, 2022 | 20.76M |
| September 30, 2022 | 22.40M |
| June 30, 2022 | 24.34M |
| March 31, 2022 | 26.35M |
| December 31, 2021 | 28.64M |
| September 30, 2021 | 30.41M |
| Date | Value |
|---|---|
| June 30, 2021 | 30.92M |
| March 31, 2021 | 29.33M |
| December 31, 2020 | 26.44M |
| September 30, 2020 | 25.61M |
| June 30, 2020 | 24.83M |
| March 31, 2020 | 25.30M |
| December 31, 2019 | 24.96M |
| September 30, 2019 | 23.45M |
| June 30, 2019 | 22.30M |
| March 31, 2019 | 19.92M |
| December 31, 2018 | 17.25M |
| September 30, 2018 | 15.04M |
| June 30, 2018 | 13.20M |
| March 31, 2018 | 11.52M |
| December 31, 2017 | 10.20M |
| September 30, 2017 | 9.139M |
| June 30, 2017 | 7.678M |
| March 31, 2017 | 6.849M |
| December 31, 2016 | 5.988M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Accuray, Inc. | 37.80M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 60.33M |
| ResMed, Inc. | 378.28M |
| Rockwell Medical, Inc. | -- |